8,440
Participants
Start Date
February 16, 2022
Primary Completion Date
March 5, 2024
Study Completion Date
October 31, 2024
Tranexamic acid (TXA)
TXA 1 gram bolus (2 grams for patients over 100 kg) intravenously (IV) administered within 10 minutes of the first surgical incision, followed by 1 additional gram given intravenously at 2-4 hours of surgery or prior to skin closure, at the discretion of the anesthesiologist (e.g. IV bolus at 2-4 hours of surgery, at skin closure, or the 1 additional gram given as a continuous infusion throughout the surgical procedure).
Placebo (0.9 % Saline)
Placebo (0.9 % normal saline) 1 gram bolus (2 grams for patients over 100 kg) intravenously (IV) administered within 10 minutes of the first surgical incision, followed by 1 additional gram given intravenously at 2-4 hours of surgery or prior to skin closure, at the discretion of the anesthesiologist (e.g. IV bolus at 2-4 hours of surgery, at skin closure, or the 1 additional gram given as a continuous infusion throughout the surgical procedure).
St. Boniface Hospital, Winnipeg
University of Manitoba- HSC Campus, Winnipeg
Grace Hospital, Winnipeg
Health Sciences North Research Institute, Greater Sudbury
Kingston Health Sciences Centre, Kingston
London Health Sciences Centre, London
Ottawa Hospital Research Institute- Civic and General sites, Ottawa
Hôpital Montfort, Ottawa
Humber River Hospital, Toronto
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Health Sciences Centre Foundation, Manitoba
OTHER
The Ottawa Hospital
OTHER
University of Manitoba
OTHER